Wells Fargo raised the firm’s price target on HealthEquity to $93 from $89 and keeps an Overweight rating on the shares. The firm notes the company put up beat and raise in Q3. HealthEquity continues to see solid account and AUM growth, bolstered by a favorable rate environment and Enhanced Rate adoption.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HQY:
- HealthEquity Reports Third Quarter Ended October 31, 2023 Financial Results
- HQY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- HealthEquity Sets Date to Announce Third Quarter Results
- HealthEquity Named Top Workplace in Rankings Nationwide
- HealthEquity price target raised to $85 from $72 at Deutsche Bank
Questions or Comments about the article? Write to editor@tipranks.com